Experts Urge Stronger Chinese Supply Chain Surveillance to Protect U.S. Consumer

Drug Industry Daily
A A
Although great strides have been made by Chinese officials to improve the quality of drugs made in the country, more needs to be done, according to U.S. regulators and drug safety advocates.

To View This Article:

Login

Subscribe To Drug Industry Daily